rs1057519974

Positions:

• chr8-73946734-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2 PP3_Moderate

The NM_005648.4(ELOC):​c.235T>A​(p.Tyr79Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: not found (cov: 32)
• Consequence: ELOC NM_005648.4 missense
• Clinical Significance: Likely pathogenic no assertion criteria provided P:1
• Conservation: PhyloP100: 6.95

Genes affected

ELOC (HGNC:11617): (elongin C) This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been identified. [provided by RefSeq, Mar 2011]

ELOC (HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 4 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.866

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
ELOC	NM_005648.4	c.235T>A	p.Tyr79Asn	missense_variant	4/4	ENST00000520242.6	NP_005639.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
ELOC	ENST00000520242.6	c.235T>A	p.Tyr79Asn	missense_variant	4/4	1	NM_005648.4	ENSP00000428171.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Significance: Likely pathogenic

Submissions summary: Pathogenic:1

Revision: no assertion criteria provided

Submissions by phenotype

Papillary renal cell carcinoma type 1 Pathogenic:1

Likely pathogenic, no assertion criteria provided

literature only

Database of Curated Mutations (DoCM)

May 31, 2016

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.99
BayesDel_addAF	Uncertain	0.099	D
BayesDel_noAF	Benign	-0.10
CADD	Uncertain	25
DANN	Uncertain	0.98
DEOGEN2	Benign	0.16	T;T;.;T;T;T;T;T;.
Eigen	Uncertain	0.44
Eigen_PC	Uncertain	0.49
FATHMM_MKL	Pathogenic	0.98	D
LIST_S2	Uncertain	0.91	.;D;D;.;.;.;.;.;D
M_CAP	Benign	0.032	D
MetaRNN	Pathogenic	0.87	D;D;D;D;D;D;D;D;D
MetaSVM	Benign	-0.50	T
MutationAssessor	Pathogenic	3.1	M;M;.;M;M;M;M;M;.
PrimateAI	Pathogenic	0.87	D
PROVEAN	Pathogenic	-7.4	D;.;D;D;D;D;D;D;D
REVEL	Uncertain	0.34
Sift	Uncertain	0.027	D;.;D;D;D;D;D;D;D
Sift4G	Uncertain	0.036	D;D;D;D;D;D;D;D;.
Polyphen		0.14	B;B;.;B;B;B;B;B;.
Vest4		0.63
MutPred		0.76		Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);.;Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);Gain of MoRF binding (P = 0.0749);
MVP		0.77
MPC		2.3
ClinPred		1.0	D
GERP RS		4.4
Varity_R		0.90
gMVP		0.98

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1057519974; hg19: chr8-74858969; COSMIC: COSV53024344;